Skip to content

Healthcare Professionals

Provide a tailored and clinically proven treatment plan for your tinnitus patients with Lenire.

Become a partner clinic
tinnitus patient in consultation with healthcare professional

The Role of Healthcare Professionals

The Lenire tinnitus treatment device is used as part of a treatment plan prescribed and supervised by a qualified healthcare professional. From the very first assessment, healthcare professionals such as Audiologists, Acousticians, Consultant Otolaryngologists or ENT surgeons tailor the treatment to achieve the best outcome for the patient.

  1. Initial Assessment


    Patients get an audiometric evaluation and tinnitus assessment from their healthcare professional to see if Lenire is suitable for them. Lenire will not be suitable for every patient so the healthcare professional may decide to refer them to other treatments.

  2. Device Fitting


    If Lenire is deemed suitable and prescribed by the healthcare professional, Lenire’s audio and tongue stimulations are configured and calibrated to the patient’s characteristics by the healthcare professional during the initial fitting appointment. This allows the healthcare professional to tailor the treatment to the individual patient based on their hearing profile and tinnitus experience.

    There are follow up appointments, after the fitting appointment, so the healthcare professional can monitor how the patient is progressing with treatment.

  3. Follow-up Appointments


    A follow-up appointment with the patient should take place approximately six to 12 weeks into the treatment plan. Another follow-up appointment should take place a further six to 12 weeks after the first.

    This allows the healthcare professional to assess the patient’s progress. It’s possible the healthcare professional may decide to change the configuration of Lenire’s stimulation during a follow up appointment to get the best outcome for the patient.

    If the patient has any issues throughout the treatment plan, it’s important that they contact their healthcare professional as a visit may be required in which the device’s stimulation settings are readjusted.

  4. Continued Use


    At the end of the prescribed treatment plan, the healthcare professional will advise each patient on their continued use of the Lenire device thereafter.

Treat your Patients with Lenire

Depending on what type of healthcare professional you are there are different ways your patients can access this evidence-based treatment. There are two options: refer your patients to a partner clinic or provide them with Lenire directly by becoming a partner.


If you’re an Audiologist, Consultant Otolaryngologist or ENT surgeon, you can provide Lenire in your practice by becoming a Lenire partner clinic. You’ll get a full training programme about Lenire, how to use it, how it works and the science of bimodal neuromodulation. Our clinical affairs team offer an ongoing support structure, with other partner clinics, to communicate and collaborate towards better patient outcomes.


If you’re a GP or any other healthcare professional, you can refer your tinnitus patients to Lenire partner clinics. Our trusted, trained and dedicated partners are qualified ENTs and Audiologists who provide the Lenire device and treatment plan. Find your nearest Lenire provider to refer your patients.

What Patients are Suitable for Lenire?

The Lenire device is intended for use in adults over 18 years of age, who have experienced chronic subjective tinnitus for three months or longer. Lenire can be used safely in patients with hyperacusis.

However, Lenire is not recommended if a patient has any of the conditions described below.

Patients should not use Lenire if:

  • They have a pacemaker, defibrillator or any other active implantable device.
  • They are pregnant, unless directed by a doctor.
  • They suffer from epilepsy or any other condition that may result in loss of consciousness.
  • They suffer from any condition that causes impaired sensitivity of the tongue.
  • They have lesions, sores or inflammation of the oral cavity.
  • They are suffering from any intermittent or chronic neuralgia in the head and neck area.

Fitting range

Please note that some patients with severe hearing loss may not be eligible for Lenire. Lenire cannot be configured if a patients has a hearing threshold (AC) in either ear of >40dBHL in the range of 250Hz – 1kHz or >80dBHL in the range of 2kHz- 8kHz.

Other Resources for Healthcare Professionals

Published Research Papers

Find our published research papers from large scale clinical trials of Lenire.

Lenire and clinical trials

The Lenire tinnitus treatment device has been evaluated in four clinical trials to date which had more than 500 participants combined. The results are very promising for those with tinnitus.

Keep up to date

Our newsletter will keep you up to date with news about Lenire and our research in the field of tinnitus.